Caxton Associates LP G1 Therapeutics, Inc. Transaction History

Caxton Associates LP

  • $2.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$5.19 - $13.5 $93,902 - $244,255
18,093 New
18,093 $98,000
Q2 2022

Aug 15, 2022
BUY
$4.04 - $8.51 $86,407 - $182,011
21,388 New
21,388 $106,000
Q2 2020

Aug 14, 2020
SELL
$9.57 - $24.37 $128,123 - $326,265
-13,388 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$9.07 - $26.32 $121,429 - $352,372
13,388 New
13,388 $148,000

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email